Cargando…

Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model

To reveal the pathomechanisms of glaucoma, a common cause of blindness, suitable animal models are needed. As previously shown, retinal ganglion cell and optic nerve degeneration occur in βB1-CTGF mice. Here, we aimed to determine possible apoptotic mechanisms and degeneration of different retinal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Maximilian, Reinehr, Sabrina, Mueller-Buehl, Ana M., Doerner, Johanna D., Fuchshofer, Rudolf, Stute, Gesa, Dick, H. Burkhard, Joachim, Stephanie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922353/
https://www.ncbi.nlm.nih.gov/pubmed/33671472
http://dx.doi.org/10.3390/ijms22041997
_version_ 1783658669629505536
author Weiss, Maximilian
Reinehr, Sabrina
Mueller-Buehl, Ana M.
Doerner, Johanna D.
Fuchshofer, Rudolf
Stute, Gesa
Dick, H. Burkhard
Joachim, Stephanie C.
author_facet Weiss, Maximilian
Reinehr, Sabrina
Mueller-Buehl, Ana M.
Doerner, Johanna D.
Fuchshofer, Rudolf
Stute, Gesa
Dick, H. Burkhard
Joachim, Stephanie C.
author_sort Weiss, Maximilian
collection PubMed
description To reveal the pathomechanisms of glaucoma, a common cause of blindness, suitable animal models are needed. As previously shown, retinal ganglion cell and optic nerve degeneration occur in βB1-CTGF mice. Here, we aimed to determine possible apoptotic mechanisms and degeneration of different retinal cells. Hence, retinae were processed for immunohistology (n = 5–9/group) and quantitative real-time PCR analysis (n = 5–7/group) in 5- and 10-week-old βB1-CTGF and wildtype controls. We noted significantly more cleaved caspase 3(+) cells in βB1-CTGF retinae at 5 (p = 0.005) and 10 weeks (p = 0.02), and a significant upregulation of Casp3 and Bax/Bcl2 mRNA levels (p < 0.05). Furthermore, more terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL(+)) cells were detected in transgenic mice at 5 (p = 0.03) and 10 weeks (p = 0.02). Neurofilament H staining (p = 0.01) as well as Nefh (p = 0.02) and Tubb3 (p = 0.009) mRNA levels were significantly decreased at 10 weeks. GABAergic synapse intensity was lower at 5 weeks, while no alterations were noted at 10 weeks. The glutamatergic synapse intensity was decreased at 5 (p = 0.007) and 10 weeks (p = 0.01). No changes were observed for bipolar cells, photoreceptors, and macroglia. We conclude that apoptotic processes and synapse loss precede neuronal death in this model. This slow progression rate makes the βB1-CTGF mice a suitable model to study primary open-angle glaucoma.
format Online
Article
Text
id pubmed-7922353
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79223532021-03-03 Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model Weiss, Maximilian Reinehr, Sabrina Mueller-Buehl, Ana M. Doerner, Johanna D. Fuchshofer, Rudolf Stute, Gesa Dick, H. Burkhard Joachim, Stephanie C. Int J Mol Sci Article To reveal the pathomechanisms of glaucoma, a common cause of blindness, suitable animal models are needed. As previously shown, retinal ganglion cell and optic nerve degeneration occur in βB1-CTGF mice. Here, we aimed to determine possible apoptotic mechanisms and degeneration of different retinal cells. Hence, retinae were processed for immunohistology (n = 5–9/group) and quantitative real-time PCR analysis (n = 5–7/group) in 5- and 10-week-old βB1-CTGF and wildtype controls. We noted significantly more cleaved caspase 3(+) cells in βB1-CTGF retinae at 5 (p = 0.005) and 10 weeks (p = 0.02), and a significant upregulation of Casp3 and Bax/Bcl2 mRNA levels (p < 0.05). Furthermore, more terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL(+)) cells were detected in transgenic mice at 5 (p = 0.03) and 10 weeks (p = 0.02). Neurofilament H staining (p = 0.01) as well as Nefh (p = 0.02) and Tubb3 (p = 0.009) mRNA levels were significantly decreased at 10 weeks. GABAergic synapse intensity was lower at 5 weeks, while no alterations were noted at 10 weeks. The glutamatergic synapse intensity was decreased at 5 (p = 0.007) and 10 weeks (p = 0.01). No changes were observed for bipolar cells, photoreceptors, and macroglia. We conclude that apoptotic processes and synapse loss precede neuronal death in this model. This slow progression rate makes the βB1-CTGF mice a suitable model to study primary open-angle glaucoma. MDPI 2021-02-17 /pmc/articles/PMC7922353/ /pubmed/33671472 http://dx.doi.org/10.3390/ijms22041997 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Weiss, Maximilian
Reinehr, Sabrina
Mueller-Buehl, Ana M.
Doerner, Johanna D.
Fuchshofer, Rudolf
Stute, Gesa
Dick, H. Burkhard
Joachim, Stephanie C.
Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model
title Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model
title_full Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model
title_fullStr Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model
title_full_unstemmed Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model
title_short Activation of Apoptosis in a βB1-CTGF Transgenic Mouse Model
title_sort activation of apoptosis in a βb1-ctgf transgenic mouse model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922353/
https://www.ncbi.nlm.nih.gov/pubmed/33671472
http://dx.doi.org/10.3390/ijms22041997
work_keys_str_mv AT weissmaximilian activationofapoptosisinabb1ctgftransgenicmousemodel
AT reinehrsabrina activationofapoptosisinabb1ctgftransgenicmousemodel
AT muellerbuehlanam activationofapoptosisinabb1ctgftransgenicmousemodel
AT doernerjohannad activationofapoptosisinabb1ctgftransgenicmousemodel
AT fuchshoferrudolf activationofapoptosisinabb1ctgftransgenicmousemodel
AT stutegesa activationofapoptosisinabb1ctgftransgenicmousemodel
AT dickhburkhard activationofapoptosisinabb1ctgftransgenicmousemodel
AT joachimstephaniec activationofapoptosisinabb1ctgftransgenicmousemodel